📣 We’re investing a further £1 million to create new drugs that can protect mitochondria and slow or stop #Parkinsons parkinsons.org.uk/news/parkinson…

In case you haven't seen it: a major step forward for a new possible disease modifying treatment for Parkinson's, based on the discovery of the LRRK2 gene. parkinsons.org.uk/news/biogen-st…

Nice piece by the Parkinson's UK Research Comms team on this Parkinson's and diabetes. parkinsons.org.uk/news/link-foun…

Excellent piece on BBC Radio 4 Today about the funding crisis facing UK medical research in the wake of the pandemic. Medical research charities desperately need Government support to continue funding life saving and changing research. Sir Paul Nurse 👏👏👏💪

In our global effort to promote even stronger collaboration, we’re enabling science to go further, faster by supporting diverse teams—each advancing targeted basic research to move us toward meaningful advancements in the fight against #Parkinsons disease.

amrc.org.uk/without-charit…

Very excited to share this news: important new funding for Chord Therapeutics to develop a new treatment for life-threatening autoimmune diseases, #neuromyelitisoptica and generalised #myastheniagravis! chordtherapeutics.com/news/chord-the…

Have a look at this great story about the trial we at Parkinson's UK are funding to find a treatment for hallucinations in Parkinson's. dailymail.co.uk/health/article…

Hallucinations in Parkinson's can start slowly but become very problematic. If you live in the UK and could be interested in a trial, search the Parkinson's UK Take Part Hub.

This campaign highlights the surprising, frustrating extent of all the things that people living with Parkinson's may have difficulty with at times. Let's work together to give them back those things, through research. x.com/ParkinsonsUK/s….

Excited to be part of this story! Parkinson's UK's Virtual Biotech partnering with MJFF and Neurolixis to get a new treatment for dyskinesia into clinical testing. parkinsons.org.uk/news/new-trial…

GDNF Rides Again! At Parkinson's UK we announce the creation of Vivifi Biotech, to move infused GDNF forward as a potential treatment for Parkinson's. See more here medium.com/parkinsons-uk/….

Why GDNF Now? My explanation of the reasoning behind today's announcement. More detail at medium.com/parkinsons-uk/…

You can follow #GenevaPharmaNetwork on LinkedIn since Sept. 2013: linkedin.com/groups/5165952/ Join #GPN (free membership) at: lnkd.in/dcz6t54 and attend our next virtual event on “#COVID19 VACCINE ACCESS STRATEGIES” in develop-ed/-ing countries. on March 5th 12:30-1:45pm

Any friends or colleagues in the Geneva-Lausanne region (who are not already members!): The GPN is one way to keep your professional network alive, now and in the future.

This #VolunteersWeek2021 we're celebrating the hundreds of Parkinson's UK volunteers who are helping drive forward progress in research. Find out more about how volunteers are involved in #Parkinsons research in our latest blog 👇 link.medium.com/iJldtCLrJgb

New report on the impact and unmet need due to dementia in Parkinson's. Not the first symptom most people think of, but actually very common - most people will be affected. Investmnet in effective new treatments needed! parkinsons.org.uk/sites/default/…

Excited to announce the acquisition of Chord Therapeutics by Merck KGaA. There are real synergies here, for people living with NMOSD and myasthenia gravis. Thanks to Tom Plitz, Claudio Nessi, Francesco Draetta and everyone involved at Omega and Merck! chordtherapeutics.com/news/merck-acq…

Next time you use Wikipedia, why not click on "Donate"? Worth at least as much as a week's wine budget. And, thanks to the army of unpaid contributors who provide the content!

In case you missed it: World Parkinson's Day today. There is more excitement about new treatments today than I can remember ever before! parkinsons.org.uk/get-involved/w…